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7. EURODIAB ACE Study Group (2000) Vaccination is a challenge for the immune system with the aim of protecting the recipient against wild-type infection. On a population base, vaccination will also modify the epidemiological pattern of wild-type infection. Mass-vaccination reduces circulation of wild-type infection, resulting in a change from endemic to sporadic infections with incidental outbreaks. This is observed in some regions of the Netherlands where a minority population lives that refuses vaccination for religious reasons [2] . Such a change in epidemiology can have paradoxical and unintended effects because it results in postponement of infection to a later mean age [3] .The ultimate outcome of mass-vaccination will be the establishment of herd-immunity with disappearance of the pathogen from the community and protection also for the non-immune, e. g. those who are not vaccinated. The authors did not incorporate such non-stochastic effects in their analyses, which probably will confound the outcome, at least for some of the vaccinations included. Such effects will furthermore hamper a proper comparison between the participating centres, which have their own history of immunisations and because of that will vary for the incidence of wild-type infections. Dear Sir, J.M.D. Galama asks if we can incorporate into our analysis information about indirect effects of vaccination such as the establishment of herd-immunity, the postponement of infection to later ages and the eradication of pathogens from the community. Clearly it would be very difficult to collect data on such factors in dispersed populations over the lengthy periods during which the children in our study were at risk of these infections. Because the children in our control groups were drawn from the same populations as those with Type I diabetes any indirect effects of vaccination might be expected to affect both diabetic and control subjects equally. We therefore argue that the conclusions from our comparisons of the two relate to the direct effects of vaccination and that any modifications to the epidemiology of infectious diseases produced by mass vaccination are unlikely to confound our comparisons. Although we agree that such indirect effects could have a role in explaining the large variation in incidence within Europe, we would point out that the purpose of our study was not to make comparisons between participating centres. Sincerely, C. C. Patterson, G. Dahlquist, G. SoltØsz (on behalf of the EURODIAB Substudy 2 Study Group) Letters to the editor 684
